Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down – Here’s Why

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $17.36, but opened at $16.72. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.78, with a volume of 3,158 shares trading hands.

Wall Street Analyst Weigh In

A number of research firms have recently commented on TLX. William Blair reiterated an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th. Wedbush began coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research note on Thursday. They set an “outperform” rating and a $22.00 target price on the stock.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The stock has a 50 day moving average price of $16.76 and a 200 day moving average price of $16.85.

Institutional Investors Weigh In On Telix Pharmaceuticals Limited American Depositary Shares

An institutional investor recently bought a new position in Telix Pharmaceuticals Limited American Depositary Shares stock. ABC Arbitrage SA bought a new position in shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) during the first quarter, according to its most recent filing with the SEC. The fund bought 26,939 shares of the company’s stock, valued at approximately $451,000.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.